Ortho-substituted polychlorinated biphenyls (PCBs) have been shown to alter microsomal Ca 2ϩ transport by selective interaction with ryanodine receptors (RyRs) of muscle sarcoplasmic reticulum (SR) and brain endoplasmic reticulum. 2ϩ release channels localized within ER and SR membranes, and the mitochondrial permeability transition pore (1, 2). Two classes of ligand-gated Ca 2ϩ release channels are localized within specialized regions of ER/SR: (i) IP 3 -sensitive Ca 2ϩ release channels (IP 3 Rs) and (ii) ryanodine-sensitive Ca 2ϩ release channels (RyRs). Although these two classes of Ca 2ϩ release channels share sequence homology and structural similarity, their differences in pharmacology, conductance properties, distribution among various tissues, and distribution within individual cell types suggest different functional roles in cellular signaling. Microsomal Ca 2ϩ release channels exist in association with several accessory proteins. One of the accessory proteins, immunophilin FKBP12 is tightly associated with both IP 3 R and RyR proteins (3). The association of FKBP12 with Ry 1 R channel complex seems to be important in regulating aspects of Ry 1 R channel gating behavior because its removal from Ry 1 R promotes subconductance states, increases open ABBREVIATIONS: SERCA, sarcoplasmic/endoplasmic reticulum Ca 2ϩ /ATPase; APIII, antipyrylazo III; CICR, Ca 2ϩ -induced Ca 2ϩ release; DMSO, dimethylsulfoxide; ER, endoplasmic reticulum; FKBP12, FK 506 binding protein of 12 kDa; IP 3 R, inositol-1,4,5-trisphosphate receptor; PCB, polychlorinated biphenyl; RyR, ryanodine receptor; Ry 1 R, skeletal isoform of ryanodine receptor; SR, sarcoplasmic reticulum; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid.
sensitive Ca 2ϩ leak unmasked by thapsigargin nor enhances the loading capacity of SR vesicles. PCB 95 alone enhances thapsigargin evoked Ca 2ϩ release and therefore diminishes the loading capacity of SR vesicles. However, in the presence of micromolar ryanodine, PCB 95 dose-dependently eliminates the Ca 2ϩ leak unmasked by thapsigargin and significantly enhances the loading capacity of SR vesicles. The actions of PCB 95 on SR-loading capacity are additive with those of FK 506. Structural specificity for these novel actions are further demonstrated with coplanar PCB 126, which is inactive toward Ry 1 R and lacks the ability to alter the Ca 2ϩ leak pathway. The results reveal that FKBP12 relates ryanodine-insensitive Ca 2ϩ "leak" and ryanodine-sensitive Ca 2ϩ channel efflux pathways of SR by modulating distinct conformations Ry 1 R complexes. Noncoplanar PCBs, like PCB 95, alter SR Ca 2ϩ buffering by an FKBP12-mediated mechanism. An immunophilin-based mechanism could account for the toxic actions attributed to certain noncoplanar PCB congeners.
Temporal and spatial changes in intracellular Ca
2ϩ are known to regulate a large number of cellular functions. Because Ca 2ϩ plays a central role in signaling, cells have evolved a very effective array of pumps and exchangers to extrude Ca 2ϩ across the plasmalemma or store Ca 2ϩ within intracellular organelles. SERCA pumps, for example, effectively accumulate Ca 2ϩ within the lumen of ER and SR, thereby creating a major intracellular Ca 2ϩ buffer. Macromolecules that contribute to the rise in cytosolic Ca 2ϩ include ligand-and voltage-operated Ca 2ϩ entry channels within the plasma membrane, Ca 2ϩ release channels localized within ER and SR membranes, and the mitochondrial permeability transition pore (1, 2) . Two classes of ligand-gated Ca 2ϩ release channels are localized within specialized regions of ER/SR: (i) IP 3 -sensitive Ca 2ϩ release channels (IP 3 Rs) and (ii) ryanodine-sensitive Ca 2ϩ release channels (RyRs). Although these two classes of Ca 2ϩ release channels share sequence homology and structural similarity, their differences in pharmacology, conductance properties, distribution among various tissues, and distribution within individual cell types suggest different functional roles in cellular signaling. Microsomal Ca 2ϩ release channels exist in association with several accessory proteins. One of the accessory proteins, immunophilin FKBP12 is tightly associated with both IP 3 R and RyR proteins (3) . The association of FKBP12 with Ry 1 R channel complex seems to be important in regulating aspects of Ry 1 R channel gating behavior because its removal from Ry 1 R promotes subconductance states, increases open probability, and alters channel sensitivity toward agonists such as caffeine and Ca 2ϩ (4) . Similarly, the association of FKBP12 with IP 3 R seems to stabilize the channel complex and promote optimal cooperativity among subunits (5) . Chemical substances that modify the native interaction between FKBP12 and RyRs would be expected to alter microsomal Ca 2ϩ transport and influence one or more Ca 2ϩ -dependent processes downstream.
Results from in vivo studies with animals (6) , in vitro studies with cell cultures (7) , and studies with subcellular membrane preparations (8 -10) 1 have revealed that certain ortho-substituted PCB congeners possess potent biological activity toward the nervous system. Inhibition of Ca 2ϩ -dependent ATPase activity has been suggested to be a major molecular mechanism by which these noncoplanar PCBs induce neurotoxicity (10) . Recently, certain PCBs have been demonstrated to mobilize microsomal Ca 2ϩ by direct interaction with RyRs localized within muscle SR and neuronal ER, without markedly altering SERCA pumps or IP 3 R activities (8) . 1 The exact mechanism by which PCB 95 alters microsomal Ca 2ϩ transport and the function of RyRs is unclear. One of the most potent and efficacious PCB congeners found to alter RyRs activity, noncoplanar PCB 95 (2,2Ј,3,5Ј,6-pentachlorobiphenyl) has also been recently shown to alter neuroplasticity in the rat hippocampal slice preparations (11) . PCB 95 administered to rats perinatally results in offspring exhibiting significant depression in locomotor activity and altered performance in the radial arm maze, which assesses spatial learning and memory functions.
2 However, the relationship between the effect of PCB 95 on RyR functions and its effect on neuroplasticity in mammalian brain is unknown.
In the current study, we used skeletal SR enriched in FKBP12/Ry 1 R complex to elucidate the mechanism by which PCB 95 alters SR Ca 2ϩ transport. A significant new finding was that PCB 95 mobilizes Ca 2ϩ through an FKBP12-dependent mechanism. Dissociation of FKBP12 from the Ry 1 R channel complex with FK 506 completely negates PCB 95-induced Ca 2ϩ release from skeletal SR, even though the channel remains fully responsive to caffeine and Ca 2ϩ . FK 506 is found to dramatically enhance the steady state filling capacity of SR vesicles for Ca 2ϩ , consistent with the role of FKBP12 in regulating channel and leak states of Ry 1 R (5, 12). PCB 95 is shown to significantly enhance ryanodinesensitive Ca 2ϩ release and concomitantly eliminate a ryanodine-insensitive Ca 2ϩ "leak" normally present in SR membranes. The present results reveal that ortho-substituted PCB 95 alters Ca 2ϩ buffering in the microsome by directly interacting with the FKBP12/RyR complex. Considering the important role of FKBP12 in regulating immune and neuronal cell functions, as well as the differential expression of RyR isoforms in distinct regions of the central and peripheral nervous systems of mammals (13) , this newly identified mechanism may play an important role in the toxicity of noncoplanar PCBs.
Experimental Procedures
Materials. Neat Ultra-certified PCB congeners (purity, Ͼ 99%) were purchased from Ultra Scientific (North Kingstown, RI). [ 3 H]Ryanodine (specific activity, 60-80 Ci/mmol; purity, Ͼ 99%) was obtained from New England Nuclear (Wilmington, DE). FK 506 and rapamycin (purity, Ͼ 95%) were purchased from Signal Transduction (San Diego, CA). Thapsigargin was obtained from Sigma Chemical (St. Louis, MO). All other chemicals were of the highest grade available commercially.
Membrane preparations. Junctional SR membrane vesicles enriched in the skeletal isoform of ryanodine receptor, Ry 1 R, were prepared from fast-twitch skeletal muscle obtained from 3-4-kg male New Zealand White rabbits according to a previously reported method (8) .
[ 50 and Hill coefficients were calculated by sigmoidal curve fitting of the dose-response curves using ENZFITTER computer software (Elsevier-Biosoft, Cambridge, UK). Experiments were performed in duplicate and repeated at least twice with two different membrane preparations. Ca 2؉ transport measurements. Net Ca 2ϩ flux across the SR membrane vesicles was monitored by metallochromic dye APIII according to a previously reported method (8) . Vesicles were actively loaded to capacity by serial additions of 24 nmol of CaCl 2 in the presence of ATP and a regenerating system consisting of creatine phosphokinase and phosphocreatine at 37°. The abilities of FK 506 and rapamycin to inhibit PCB 95-induced Ca 2ϩ release from loaded SR membrane vesicles were determined by preincubating the vesicles with 0-50 M rapamycin before Ca 2ϩ loading or adding 50 M FK 506 3 min before the introduction of PCB 95. PCB 95 (1 M) was introduced to the assay to assess its ability to mobilize Ca 2ϩ from the drug-treated vesicles.
Caffeine-induced Ca 2ϩ release and CICR responses of SR vesicles were studied in the presence of FK 506 or PCB 95. FK 506 (50 M) or 6 l of DMSO (control) was introduced to the actively loaded SR vesicles, and the assay mixture was permitted to incubate for ϳ3 min at 37°. Then, 1 M PCB 95 was added and immediately followed by 10 mM caffeine or 84 nmol of Ca 2ϩ to assess the responsiveness of the Ca 2ϩ release channel to modulators known to have effector sites on the Ry 1 R protein. In experiments aimed at assessing CICR, once the release phase was complete, 500 M ryanodine was introduced into the assay mixture to fully block Ry 1 R, thus initiating active reaccumulation of Ca 2ϩ into the vesicles. The ability of selected PCB congeners to modulate thapsigarginevoked Ca 2ϩ efflux from SR was examined in the presence or absence of channel-blocking concentration of ryanodine. Membrane vesicles were loaded to near capacity as described above. Once the loading phase was complete, 375 nM thapsigargin was introduced to inhibit the SERCA pump and therefore block active Ca 2ϩ uptake immediately after the addition of 5 M PCB 95 or PCB 126. The ability of PCBs to modulate the ryanodine-insensitive Ca 2ϩ efflux was studied by preincubating the vesicles for 3 min with 0-10 M PCB 95 or 5 M PCB 126 in the presence of 500 M ryanodine to block all ryanodinesensitive Ca 2ϩ channels before initiating Ca 2ϩ loading (12) . Ryanodine-insensitive Ca 2ϩ efflux was then evoked by the addition of 375 nM thapsigargin.
The ability of FK 506 to alter thapsigargin-evoked Ca 2ϩ efflux from SR vesicles was also studied. FK 506 (50 M) or 6 l of DMSO (control) was added to actively loaded SR vesicles, and the reaction mixture was allowed to incubate for ϳ3 min before the addition of 375 nM thapsigargin to induce Ca 2ϩ efflux. The ability of 50 M FK 506 to alter ryanodine-insensitive Ca 2ϩ efflux was examined by performing the measurements with ryanodine-pretreated SR vesicles. In these experiments, SR vesicles were pretreated for 3 min with 500 M ryanodine before loading with Ca 2ϩ . Once the loading was complete, 50 M FK 506 or 6 l of DMSO (control) was introduced, and the reaction mixture was allowed to incubate for 3 min before the addition of 375 nM thapsigargin to induce Ca 2ϩ efflux. At the end of each experiment, absorbance signals were calibrated by the addition of 1 g of the Ca 2ϩ ionophore A23187 followed by additions of 24 nmol of CaCl 2 . Ca 2ϩ ionophore A23187 (1 g) was added to each assay to release the accumulated Ca 2ϩ from the vesicles. Ca 2ϩ -loading capacities under various experimental conditions were determined as the amount of ionophore-releasable Ca 2ϩ calculated from the difference between the absorbance signal before and after the addition of A23187. The dye signal was calibrated for linearity with two additions of 24 nmol of CaCl 2 at the end of each experiment. Data were analyzed by with one-tailed paired t test (␣ ϭ 0.05). The measurements were repeated at least three times with at least two different membrane preparations. 3 H]ryanodine occupancy in a dose-dependent manner. The IC 50 values for FK 506 and rapamycin are ϳ40 M and ϳ30 M, respectively, which parallel the slightly higher binding affinity of rapamycin to FKBP12 than that of FK 506 (14) . The values of IC 50 are independent of the concentrations of PCB 95 (Table 1) . At concentrations known to dissociate FKBP12 from Ry 1 R (4), both FK 506 and rapamycin negated PCB 95-enhanced binding of [ 3 H]ryanodine to Ry 1 R, which suggests that PCB 95 enhances the SR Ca 2ϩ release channel activity in a FKBP12-dependent manner.
Results and Discussion
Ca 2ϩ transport measurements with the metallochromic indicator APIII reveal that the addition of 1 M PCB 95 induced a net Ca 2ϩ efflux from actively loaded SR vesicles ( Fig. 2A, trace a) . FK 506 (50 M) introduced ϳ3 min before the addition of 1 M PCB 95 completely eliminated the response to PCB 95 ( Fig. 2A, trace b) . Similarly, preincubation of the vesicles for 3 min with 0-50 M rapamycin before Ca Table 1 ). Fig. 2C shows that 50 M FK 506 in the transport assay altered neither the slope (0.57 Ϯ 0.03 absorption units/mM and 0.55 Ϯ 0.02 absorption units/mM for FK 506 and DMSO control, respectively; p Ͼ 0.1) nor the regression coefficient (r Ͼ 0.996 for both conditions) of the dye calibration curves, which indicates that the drug does not (17) . Although FK 506 completely eliminated responses of Ry 1 R to PCB 95, the drug failed to inhibit the response of Ry 1 R to 10 mM caffeine (Fig. 3A, trace c) . The amount of SR Ca 2ϩ released by caffeine is similar regardless of the presence or absence of FK 506 (Fig. 3A , compare plateaus in traces a and b). Under the experimental conditions used here, the initial rate of caffeine-induced Ca 2ϩ release in the presence of 50 M FK 506 was the same as that of the DMSO control (6 l) (101% control, p Ͼ 0.1) (Fig. 3A , compare traces a and c; Table 2 ). However, if caffeine is introduced immediately after the addition of 1 M PCB 95 (just before PCB 95 begins to mobilize SR Ca 2ϩ ), the initial rate of Ca 2ϩ release is significantly enhanced compared with the DMSO control (200% control, p Ͻ 0.05) (Fig. 3A , compare traces a and b; Table 2 ).
Fig . 3B shows the CICR responses of actively loaded SR vesicles to the bolus addition of 84 nmol of Ca 2ϩ under various experimental conditions. FK 506 (50 M) did not significantly alter the initial rate of CICR (92% control, p Ͼ 0.1) (Fig. 3B , compare traces a and c; Table 2 ). In contrast, 1 M PCB 95 significantly enhanced the initial rate of CICR (251%, p Ͻ 0.01) (Fig. 3B , compare traces a and b; Table 2 ). Interestingly, both FK 506 and PCB 95 markedly enhanced the rate of Ca 2ϩ reaccumulation once ryanodine-sensitive Ca 2ϩ channels were fully blocked by 500 M ryanodine or 1 M ruthenium red (ruthenium red data not shown) (added once the CICR responses begin to plateau) (Fig. 3B , compare the reuptake phase in traces a-c). The maximum rates of Ca 2ϩ reuptake relative to DMSO control were 446% in the presence of FK 506, and 189% in the presence of PCB 95 (Table 2) . PCB 95 (Ͼ 1 M) further enhanced the rate and amount of Ca 2ϩ reaccumulation to a level seen with 50 M FK 506 (data not shown). In each experiment, the vesicles were loaded to near their steady state capacity in the initial loading phase. This is demonstrated by the inability of the control vesicles to reaccumulate the 84 nmol of Ca 2ϩ added for CICR once ryanodine-sensitive channels were blocked (Fig. 3B, trace a) . The addition of 1 g of ionophore A23187 at the end of the experiment shows that all of the Ca 2ϩ reaccumulated by vesicles can be quickly mobilized. Calibration with standard Ca 2ϩ solution revealed that the drugs do not interfere with dye calibration. The rates of caffeine-induced Ca 2ϩ release, CICR, and Ca 2ϩ reuptake under various experimental conditions are summarized in Table 2 . As a result, FK 506 (and rapamycin) eliminated the actions of PCB 95 on -loading capacity by converting a ryanodine-insensitive Ca 2ϩ efflux pathway (leak) normally present in SR into a ryanodine-sensitive efflux (channel), the SERCA pump inhibitor thapsigargin was used. In the absence of ryanodine, the addition of thapsigargin blocks SERCA pump activity, which would be expected to evoke Ca 2ϩ efflux from actively loaded SR vesicles through both ryanodine-sensitive and -insensitive pathways. In contrast, pump blockade on actively loaded SR vesicles pretreated with high micromolar ryanodine should only unmask Ca 2ϩ efflux through a ryanodineinsensitive pathway. Fig. 4A demonstrates that after completion of active Ca 2ϩ loading under the control condition, the addition of thapsigargin evokes release of accumulated Ca 2ϩ even though extravesicular Ca 2ϩ level is initially below threshold to activate CICR (Fig. 4A, trace a) . Pretreatment of SR vesicles with 500 M ryanodine or 2 M ruthenium red has been shown to completely block caffeine-induced Ca 2ϩ release or CICR under conditions identical to those used here (12) . Fig. 4B shows that the addition of thapsigargin after completion of Ca 2ϩ loading to SR vesicles pretreated with 500 M ryanodine unmasks a ryanodine-insensitive Ca 2ϩ efflux pathway (Fig. 4B, trace a) , consistent with previous findings (12) . The magnitude of the ryanodine-insensitive Table  2 . (Fig. 4B, trace a) . Coplanar PCB 126 (3,3Ј,4,4Ј,5-pentachlorobiphenyl; 5 M), a PCB congener lacking activity toward RyRs and SR/ER Ca 2ϩ transport (8), 1 does not alter thapsigargin-evoked Ca 2ϩ efflux regardless of whether the vesicles are pretreated with micromolar ryanodine (95% and 92% of the respective control in the absence and presence of ryanodine, respectively; p Ͼ 0.05) (Fig. 4, A and B, compare traces a and b) . In marked contrast, 5 M PCB 95 dramatically (386% of control, p Ͻ 0.025) enhanced the initial rate of Ca 2ϩ efflux evoked by the addition of 375 nM thapsigargin (Fig. 4A, compare traces a  and c) . Importantly, in the presence of channel-blocking concentration of ryanodine, the ryanodine-insensitive component of Ca 2ϩ efflux unmasked by addition of thapsigargin is greatly reduced by the presence of PCB 95 in a dose-dependent manner (Fig. 4B, compare traces a and c; Fig. 4C ). The IC 50 and Hill coefficient for the elimination of ryanodineinsensitive Ca 2ϩ leak by PCB 95 are 3.5 Ϯ 0.2 M and 0.81 Ϯ 0.05, respectively (Fig. 4C, inset) .
These results suggest that through its actions on the FKBP12/Ry 1 R complex, PCB 95 relates ryanodine-insensitive and -sensitive Ca 2ϩ efflux pathways in native SR. Micromolar ryanodine eliminates CICR and caffeine-induced Ca 2ϩ release but not a major ryanodine-insensitive Ca To determine the role of FKBP12 in regulating ryanodinesensitive and -insensitive Ca 2ϩ efflux pathways of SR, the action of FK 506 on thapsigargin-evoked Ca 2ϩ efflux from actively loaded SR membrane vesicles was examined. The addition of 50 M FK 506 to Ca 2ϩ -loaded SR depressed the initial rate of thapsigargin-evoked Ca 2ϩ release to 56% of control ( p Ͻ 0.01) (Fig. 5A, compare traces a and b) . The underlying mechanism by which FK 506 reduces the initial rate of Ca 2ϩ release from SR may stem from the ability of the drug to promote subconductances of the individual channels on dissociation of the FKBP12/Ry 1 R complex (3).
The initial rate of ryanodine-insensitive Ca 2ϩ efflux is measured with vesicles preincubated with 500 M ryanodine (Fig. 5B) . On the addition of thapsigargin, the initial rate of Ca 2ϩ release is 190 Ϯ 9 nmol/mg/min (50% of the nonryanodine-pretreated control) (Fig. 5, A and B, trace a) . A significant finding is that the introduction of 50 M FK 506 on completion of the loading phase significantly reduces the rate of ryanodine-insensitive Ca 2ϩ efflux in a manner similar to that seen for PCB 95 (Figs. 4C; Fig. 5B, compare traces a and  b) . The addition of A23187 and Ca 2ϩ standard at the end of each experiment demonstrates that all the vesicles were loaded equally, and the drugs at the concentrations used do not interfere with the APIII dye for Ca 2ϩ . Measurements of SERCA pump activity using an ATPase assay with a coupled enzyme system revealed that neither 50 M FK 506 (data not shown) nor 10 M PCB 95 (8) (8, 16) . These results suggest that PCB 95 and bastadin 5 eliminate ryanodineinsensitive Ca 2ϩ efflux by converting Ca 2ϩ leak into a full conducting channel through a molecular mechanism distinct from FK 506. The enhancement in thapsigargin-evoked Ca 2ϩ efflux with PCB 95 in the absence of channel blocker further supports the hypothesis.
FK 506 enhanced SR-loading capacity in a manner additive with PCB 95. To study the relationship of Ca 2ϩ efflux pathways and loading capacity of SR vesicles, the loading capacity of SR vesicles pretreated under various experimental conditions was measured. Fig. 6 demonstrates that the loss of ryanodine-insensitive (but not ryanodinesensitive) Ca 2ϩ efflux pathway is correlated with a signifi- ) is reached. Although variation in loading capacity has been observed between SR prepared from different animals (range, 2.8-4.0 mol/mg), vesicles from the same preparation load in a consistent manner with Յ2% variation among replicated determinations. The presence or absence of a channelblocking concentration of ryanodine has a negligible influence on the Ca 2ϩ -loading capacity of the vesicles (106 Ϯ 2% of control; Fig. 6, A and B, Control) . Pretreatment of SR with FK 506 increases loading capacity of the vesicles in a dosedependent manner with a maximal capacity and an EC 50 value of 170% of control and 18 M, respectively (Fig. 6A) . Pretreatment of SR with FK 506 and 500 M ryanodine in combination further enhances Ca 2ϩ -loading capacity of the vesicles with maximal capacity to nearly 200% of control, and the apparent potency of FK 506 increases Ͼ 2-fold to 8 M (Fig. 6A) . In the presence of 500 M ryanodine to block ryanodine-sensitive Ca 2ϩ efflux, 1 M PCB 95 significantly enhances the Ca 2ϩ -loading capacity of SR to 171% of control (Fig. 6B, PCB) . Similarly, in the presence of 500 M ryanodine, 50 M FK 506 increases loading capacity to 189% of control. In contrast, the combination of 1 M PCB 95 and 50 M FK 506 produces an additive effect with enhancement in Ca 2ϩ -loading capacity to 272% of control, which suggests that, in combination, these compounds disrupt the FKBP12/ Ry 1 R complex more profoundly than the use of either alone.
In the absence of ryanodine, pretreatment of SR vesicles with 1 M PCB 95 significantly reduces Ca 2ϩ -loading capacity to 62% of control, which is consistent with an increase in the number of high-conductance channel states in the SR membrane. In contrast, pretreatment of SR with 50 M FK 506 alone significantly enhances loading capacity to 148% of control, which is consistent with an increase in the number of subconducting channel states in the SR membrane. The combination of PCB 95 and 50 M FK 506 results in an intermediate changes in SR-loading capacity (to 79% of control), which is consistent with an increase in both full and subconducting channel states in the SR membrane. These interpretations of the observed changes in SR-loading capacity are fully consistent with the ability of each compound to eliminate a ryanodine-insensitive Ca 2ϩ leak pathway from SR measured in the release experiments (Figs. 4 and 5) .
Recently, Marks et al. (4) reported that pretreatment of intact rat soleus muscle with rapamycin increases the magnitude of response to caffeine. The increase in sensitivity of the FKBP12-deficient Ry 1 R channel to caffeine, and therefore the increase in the leakage of the SR, has been suggested to be the underlying mechanism. The current findings with actively loaded SR membranes, although generally consistent with the findings in rat soleus, extend the mechanistic interpretation of the findings by Marks et al. (3) . The ability of FK 506 and rapamycin to interact with and dissociate FKBP12 from the Ry 1 R channel complex results in two important and related changes in SR Ca 2ϩ transport: (i) an increase in loading capacity (i.e., enhanced Ca 2ϩ buffering) as a direct result of elimination of ryanodine-insensitive Ca 2ϩ leak states of Ry 1 R and (ii) an increase in the number of caffeine-responsive, albeit subconducting, Ca 2ϩ channels. This mechanism could fully account for a more robust response on caffeine stimulation in intact muscle fibers because the elevated Ca 2ϩ capacity of SR would be expected to result in a more robust response to caffeine. The current results demonstrate that FK 506 does not alter the sensitivity of channels to caffeine per se (i.e., influences initial rates of caffeine-or Ca 2ϩ -induced Ca 2ϩ release under defined loading conditions) but instead increases SR-loading capacity. An increase in extracellular Ca 2ϩ is also well known to result in SR Ca 2ϩ overload, which enhances the excitability of Ca 2ϩ release channels in cardiac muscle cells in culture (1) . The current results also reconcile why singly FK 506 or rapamycin fails to significantly alter the high affinity binding properties of [ 3 H]ryanodine but clearly influence the actions of PCB 95. In support of the current findings and interpretations, Lamb and Stephenson (19) recently showed using mechanically skinned skeletal muscle fibers that low (1 M) concentrations of FK 506 or rapamycin can potentiate SR Ca 2ϩ release induced by depolarization or caffeine. These results would be expected if the drugs at a low concentration enhance the loading capacity of the SR lumen due to loss of a 
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Ca 2ϩ leak pathway (as shown in Fig. 6 ). It was further demonstrated that a higher concentration (20 M) of FK 506 or rapamycin causes irreversible loss of depolarization-induced Ca 2ϩ release without preventing direct actions of caffeine. The latter actions are both use dependent (i.e., dependent on the frequency of depolarization) and dependent on the concentration of immunosuppressive drug. These results are consistent with a concomitant enhancement in SR filling and an increase in the number of subconducting channels on the SR membrane that apparently remain responsive to caffeine but not depolarization.
According to Marks et al. (4) , FK 506 dissociates FKBP12 from Ry 1 R and therefore increases the sensitivity of the FKBP12-deficient channel to threshold concentrations of caffeine and Ca 2ϩ in single-channel measurements in bilayer lipid membranes (by increasing mean open time and open probability). Fleischer et al. (15) also reported that by dissociating FKBP12 from Ry 1 R with FK 506, the sensitivity of SR Ca 2ϩ release to caffeine increases. A concentration of caffeine (1.0 mM) that fails to release Ca 2ϩ from native SR causes release from FK 506-pretreated SR vesicles. We report that with the optimal concentrations of caffeine (10 mM) and Ca 2ϩ (70 M), the initial rates of Ca 2ϩ release seen with FKBP12-deficient SR vesicles are similar to that of native SR. This observation most likely stems from an increase in the number of ryanodine-sensitive Ca 2ϩ channels with subconductance behavior.
In conclusion, the current results demonstrate a novel mechanism by which PCB 95 alters microsomal Ca 2ϩ regulation in muscle. Dissociation of FKBP12 from the Ry 1 R complex by FK 506 (and rapamycin) completely negates the activity of PCB 95 as measured by high affinity binding of [ 3 H]ryanodine and SR Ca 2ϩ transport under active loading conditions, which suggests that PCB 95 alters microsomal Ca 2ϩ transport through an FKBP12-dependent mechanism. Importantly, the actions of PCB 95, FK 506, and rapamycin on SR Ca 2ϩ regulation seem to stem from the ability of these compounds to alter the relationship between ryanodine-insensitive Ca 2ϩ leak and the ryanodine-sensitive Ca 2ϩ channel states of Ry 1 R, which significantly alters Ca 2ϩ buffering and release properties of SR. By virtue of their unique and specific activity, certain ortho-substituted PCBs are potent and invaluable new probes with which to understand how FKBP12 regulates microsomal Ca 2ϩ buffering under physiological and pathophysiological conditions. Furthermore, the newly identify mechanism may underlie the seemingly diverse toxicity that has recently been attributed to noncoplanar PCBs.
